Company intelligence / Profile preview

Zhejiang Meidishen Biomedical Co., Ltd.

Zhejiang, China

Ownership: Private
Development stage: Commercial

Overview

Zhejiang Meidishen Biomedical Co., Ltd. is a private Chinese biopharmaceutical company founded in 2019 and based in Zhejiang Province. The company has at least one active clinical trial evaluating the bioequivalence and safety of its ilaprazole enteric-coated tablet compared to a reference product. Its focus appears to be on generic or branded-generic drug development, particularly small molecule oral formulations for gastrointestinal conditions. There are reportedly up to 16 clinical trials associated with the company, but detailed information about additional programs or results was not found.

Therapeutic areas: Gastroenterology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

aspirin

Commercial

Beyond the preview

Go deeper on Zhejiang Meidishen Biomedical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Meidishen Biomedical Co., Ltd..

Explore the full profile